NCT05115331View on ClinicalTrials.gov

Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

July 13, 2023

Study Completion Date

November 24, 2025

Conditions
Metastatic Bone Tumor
Interventions
RADIATION

Experimental Radiation Dose

16 Gy in 2 fractions

RADIATION

Conventional Radiation Dose

8 Gy in a single fraction

Trial Locations (1)

45267

University of Cincinnati, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER